Dual-Target Repurposing Against Chikungunya Virus: Molecular Docking and Dynamics Reveal Bictegravir and Oxacillin as Promising Leads.
Chikungunya virus (CHIKV) remains an important re-emerging arboviral threat, yet no specific antiviral therapy is currently available. This study used a structure-based drug-repurposing approach to identify FDA and internationally approved drugs with potential activity against two therapeutically relevant CHIKV targets...